Meeting
2014 ASCO Annual Meeting
Comparison of ColoPrint risk classification with clinical risk in the prospective PARSC trial.
Authors
Ramon Salazar
Early Clinical Research Unit, Institut Català d'Oncologia, L´Hospitalet-Barcelona, Spain
Ramon Salazar , Jaume Capdevila , Robert Rosenberg , Bengt Glimelius , Jan Willem de Waard , Frederic Bibeau , Joost Klaase , George J. Chang , Jacobus J. M. Van Der Hoeven , Thomas Bachleitner-Hofmann , Rachel A Midgley , Edward Allen Levine , Michio Asano , Reinhard Ziebermayr , Kenneth B. Deck , Jamie Sington , Wai Lun Law , Imad Shbeeb , Lisette Stork , John Marshall
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal (Colorectal) Cancer
Track
Gastrointestinal Cancer—Colorectal and Anal
Sub Track
Colorectal Cancer
Clinical Trial Registration Number
NCT00903565
Citation
J Clin Oncol 32:5s, 2014 (suppl; abstr 3562)
DOI
10.1200/jco.2014.32.15_suppl.3562
Abstract #
3562
Poster Bd #
25
Abstract Disclosures
Similar Posters
Poster
2014 Gastrointestinal Cancers Symposium
Comparison of ColoPrint risk classification with clinical risk in the prospective PARSC trial.
First Author: Ramon Salazar
Poster
2011 Gastrointestinal Cancers Symposium
The PARSC trial: A prospective study for the assessment of recurrence risk in stage II colon cancer (CC) patients using ColoPrint.
First Author: Ramon Salazar
Poster
2012 ASCO Annual Meeting
The PARSC trial, a prospective study for the assessment of recurrence risk in stage II colon cancer patients using ColoPrint.
First Author: Ramon Salazar
Poster
2012 Gastrointestinal Cancers Symposium
The PARSC trial, a prospective study for the assessment of recurrence risk in stage II colon cancer (CC) patients using ColoPrint.
First Author: Ramon Salazar